EUVIMEDEUVIMED entdecken
Crossref

DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma

Zhongyan Zhang, Qi Zhou, Zhenchong Li, Fuxin Huang, Ke Mo, Cheng Shen, Xing Niu, Baohua Hou, Chuanzhao Zhang, Shanzhou Huang

Drug Resistance Updates · 2025-07 · 81 · 101224

DOI: 10.1016/j.drup.2025.101224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2025-07. Verfasst von Zhongyan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ferroptosis, Phenylurea Compounds. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Program key projects, National Natural Science Foundation of China, Government of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsFerroptosisPhenylurea CompoundsQuinolinesDocosahexaenoic AcidsPeroxisomal Multifunctional Protein-2Ubiquitin-Protein LigasesHumansAnimalsMiceOxidation-ReductionCell Line, TumorDrug Resistance, NeoplasmAntineoplastic AgentsXenograft Model Antitumor AssaysPeroxisomesMice, Nude

Stichwörter der Autor:innen

DTX2FerroptosisHSD17B4Lenvatinib resistancePeroxisomal β-oxidation

Substanzen

lenvatinibPhenylurea CompoundsQuinolinesDocosahexaenoic AcidsHSD17B4 protein, humanPeroxisomal Multifunctional Protein-2Antineoplastic AgentsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510080, China; The Second School of Clinical Medicine, Sout…
  • Department of General Surgery, Hui Ya Hospital of the First Affiliated Hospital, Sun Yat-Sen University, Huizhou, Guangdong 516081, China; Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen Univer…
  • Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • South China University of Technology School of Medicine, Guangzhou, Guangdong 510006, China.
  • Experimental Center of ECBio, YuanDong International Academy Of Life Sciences, Hong Kong 999077, China.
  • Experimental Center of ECBio, YuanDong International Academy Of Life Sciences, Hong Kong 999077, China. Electronic address: xniu@cmu.edu.cn.

Förderung

  • Guangzhou Municipal Science and Technology Program key projects
  • National Natural Science Foundation of China
  • Government of Guangdong Province
  • Jiangsu Association for Science and Technology
  • Chuzhou Science and Technology Program

Zitieren

APA

Zhang, Z., Zhou, Q., Li, Z., Huang, F., Mo, K., Shen, C., Niu, X., Hou, B., Zhang, C., & Huang, S. (2025). DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma. Drug Resistance Updates, 81, 101224. https://doi.org/10.1016/j.drup.2025.101224

Vancouver

Zhang Z, Zhou Q, Li Z, Huang F, Mo K, Shen C, et al. DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma. Drug Resistance Updates. 2025;81:101224. doi:10.1016/j.drup.2025.101224

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhongyan and Zhou, Qi and Li, Zhenchong and Huang, Fuxin and Mo, Ke and Shen, Cheng and Niu, Xing and Hou, Baohua and Zhang, Chuanzhao and Huang, Shanzhou},
  title = {DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {81},
  pages = {101224},
  doi = {10.1016/j.drup.2025.101224}
}
Kostenlos starten →